Literature DB >> 5549971

Factors affecting survivorship in polymyositis. A life-table study of 124 patients.

T A Medsger, H Robinson, A T Masi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5549971     DOI： 10.1002/art.1780140210

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  29 in total

1.  Improving survival in inflammatory rheumatic diseases: a neglected goal?

Authors:  Theodore Pincus; Allan Gibofsky; J Timothy Harrington
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

2.  Dermatomyositis.

Authors:  L M Tierney
Journal:  West J Med       Date:  1976-04

3.  Prognosis and mortality of polymyositis and dermatomyositis patients.

Authors:  A Airio; H Kautiainen; M Hakala
Journal:  Clin Rheumatol       Date:  2006-02-14       Impact factor: 2.980

4.  Respiration and connective tissue diseases.

Authors:  M J Walport
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

5.  Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality.

Authors:  S A Chambers; S C Charman; A Rahman; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2007-01-09       Impact factor: 19.103

6.  Fatal polymyositis: morphogenesis and ultrastructural features.

Authors:  A J Martinez; H Hooshmand; G I Mendoza; Y E Winston
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

7.  Apparent haematuria: an early sign in polymyositis.

Authors:  R Lim; J L Parker
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

8.  Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain.

Authors:  Laura Nuño-Nuño; Beatriz Esther Joven; Patricia E Carreira; Valentina Maldonado-Romero; Carmen Larena-Grijalba; Irene Llorente Cubas; Eva Gloria Tomero; María Carmen Barbadillo-Mateos; Paloma García De la Peña Lefebvre; Lucía Ruiz-Gutiérrez; Juan Carlos López-Robledillo; Henry Moruno-Cruz; Ana Pérez; Tatiana Cobo-Ibáñez; Raquel Almodóvar González; Leticia Lojo; María Jesús García De Yébenes; Francisco Javier López-Longo
Journal:  Rheumatol Int       Date:  2017-09-02       Impact factor: 2.631

9.  Drug treatment of juvenile dermatomyositis.

Authors:  G Miller; J Z Heckmatt; V Dubowitz
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

10.  Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group.

Authors:  A El-Ghobarey; G Balint; K de Ceulaer; W C Dick; W W Buchanan; T Hadidi; T A Hassan
Journal:  Postgrad Med J       Date:  1978-08       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.